John C King Insider Trading $RARX Ra Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John C King.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John C King. John C King is Chief Commercial Officer in Ra Pharmaceuticals, Inc. ($RARX).
John C King in Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John C King: Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John C King in Ra Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 0.00 | 30,658 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 21.00 | 107,000 | 2,247,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 6.20 | 190,000 | 1,178,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Sell | D | 48.00 | 10,823 | 519,504 | 0 | 10.8 K to 0 (-100.00 %) |
| Apr 18 2019 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | M | 0.00 | 15,329 | 0 | 30,658 | |
| Apr 18 2019 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Payment of Exercise | F | 21.93 | 4,506 | 98,817 | 10,823 | 15.3 K to 10.8 K (-29.40 %) |
| Apr 18 2019 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Buy | M | 0.00 | 15,329 | 0 | 15,329 | 0 to 15.3 K |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | A | 21.00 | 107,000 | 2,247,000 | 107,000 | |
| May 02 2018 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | A | 0.00 | 45,987 | 0 | 45,987 | |
| May 02 2018 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | A | 6.20 | 190,000 | 1,178,000 | 190,000 |
Page: 1